General MedicationsINJECTIONGeneric
CRYSTODIGIN
DIGITOXIN
Standard Dose
0.2MG/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview CRYSTODIGIN is listed in Drugs@FDA under application 084100 (ANDA).
Marketing status: Discontinued Active ingredient DIGITOXIN Form and strength INJECTABLE;INJECTION - 0.2MG/ML Sponsor LILLY Submission history Latest submission status date: 1978-08-28 00:00:00.
Structured Monograph
Clinical summary
Approval overview CRYSTODIGIN is listed in Drugs@FDA under application 084100 (ANDA). Marketing status: Discontinued Active ingredient DIGITOXIN Form and strength INJECTABLE;INJECTION - 0.2MG/ML Sponsor LILLY Submission history Latest submission status date: 1978-08-28 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.